![Bao Ping Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bao Ping Wang
Directeur des opérations chez Beijing Shenogen Pharma Group Ltd.
Profil
Bao Ping Wang is currently the Chief Operations Officer, Director & Deputy GM at Beijing Shenogen Pharma Group Ltd.
Prior to this, he obtained a doctorate degree from the University of Minnesota in 1990.
Postes actifs de Bao Ping Wang
Sociétés | Poste | Début |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur des opérations | 01/08/2018 |
Formation de Bao Ping Wang
University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |